Piomic Medical

Piomic Medical is a Switzerland-based startup with a mission to address the severe cost burden on global healthcare systems due to hard-to-heal wounds. With around 50 million reported cases of patients suffering from these wounds, Piomic has identified a critical need in the Health Care industry. The company was founded in 2016 and has garnered significant attention, receiving a Fr.7.50M Series A investment on 28 July 2022 from a consortium of investors including Verve Ventures, Diabetes Venture Fund, Nest Collective Foundation, and Zürcher Kantonal Bank. Piomic's innovative solution, the COMS® One Therapy System, is a portable, hand-held device designed for the treatment of hard-to-heal wounds. It incorporates optical and magnetic stimulation technologies intended to promote wound healing in chronic leg and foot ulcers. The company's focus on developing a safe and effective therapy aligns with the critical need in the healthcare industry. Piomic's approach to integrated, patient-centric care environments demonstrates promise for setting a better future for patients in need. The combination of its innovative medical device and a strong investor backing positions Piomic Medical as a compelling player in the health tech space, with potential for significant impact and growth.